Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $2.09, $0.22 better than the analyst estimate of $1.87. Revenue for the quarter came in at $2.09 billion versus the consensus estimate of $2.06 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.40-$8.55, versus the consensus of $8.40.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.